Synonyms:prilocaine, 721-50-6, Propitocaine, Citanest, N-(2-Methylphenyl)-2-(propylamino)propanamide, Prilocainum, prilocaine base, Astra 1515, o-Methyl-2-propylaminopropionanilide, Propanamide, N-(2-methylphenyl)-2-(propylamino)-, Prilocaina, 2-(Propylamino)-o-propionotoluidide, o-Propionotoluidide, 2-(propylamino)-, Astra 1512, o-Methyl-alpha-propylaminopropionanilide, 2-Methyl-alpha-propylaminopropionanilide, alpha-n-Propylamino-2-methylpropionanilide, NSC 40027, Propitocaine (JAN), CHEBI:8404, 2-(Propylamino)-N-(o-tolyl)propanamide, 2-Methyl-.alpha.-propylaminopropionanilide, NSC-40027, ASTRA-1512, ASTRA-1515, o-Propionotuluidide, 2-propylamino-, 046O35D44R, Prilocaine [USAN], PROPITOCAINE [JAN], Prilocainum [INN-Latin], Prilocaina [INN-Spanish], L-67, (+/-)-Prilocaine, HSDB 3386, Prilocaine (USP/INN), o-Propionotoluidide, 2-propylamino-, EINECS 211-957-0, BRN 2108498, Prilotekal, UNII-046O35D44R, Prilocaine [USAN:USP:INN:BAN], N-(2-methylphenyl)-N2-propylalaninamide, Spectrum_001649, L 67, PRILOCAINE [MI], PRILOCAINE [INN], N-(2-methylphenyl)-N(2)-propylalaninamide, Prestwick0_000199, Prestwick1_000199, Prestwick2_000199, Prestwick3_000199, Spectrum2_001549, Spectrum3_001052, Spectrum4_001192, Spectrum5_001175, (.+/-.)-Prilocaine, PRILOCAINE [HSDB], PRILOCAINE [VANDF], PRILOCAINE [MART.], CHEMBL1194, PRILOCAINE [USP-RS], PRILOCAINE [WHO-DD], Lopac0_001005, SCHEMBL25467, BSPBio_000157, BSPBio_002604, KBioGR_001883, KBioSS_002129, DivK1c_000846, SPBio_001398, SPBio_002078, BPBio1_000173, GTPL7276, DL-(+/-)-PRILOCAINE, EMLA COMPONENT PRILOCAINE, DTXSID7031955, PRILOCAINE [ORANGE BOOK], KBio1_000846, KBio2_002129, KBio2_004697, KBio2_007265, KBio3_001824, PRILOCAINE [EP MONOGRAPH], NINDS_000846, ORAQIX COMPONENT PRILOCAINE, HMS3604H09, HMS3651M13, HMS3884A04, PRILOCAINE [USP MONOGRAPH], ACT04759, FORTACIN COMPONENT PRILOCAINE, HY-B0137, NSC40027, PRILOCAINE COMPONENT OF EMLA, BDBM50225477, MFCD00048681, s1619, STL257086, 2-(propylamino)-N-o-tolylpropanamide, PRILOCAINE COMPONENT OF ORAQIX, AKOS015889404, AC-2100, CCG-205085, CS-1929, DB00750, PRILOCAINE COMPONENT OF FORTACIN, SDCCGSBI-0050978.P004, IDI1_000846, NCGC00015860-02, NCGC00015860-03, NCGC00015860-15, NCGC00162312-01, AS-14851, o-Methyl-.alpha.-propylaminopropionanilide, SBI-0050978.P003, DB-055611, N-(2-methylphenyl)-N~2~-propylalaninamide, AB00053665, FT-0603506, FT-0660568, SW196783-3, .alpha.-n-Propyl-amino-2-methylpropionanilide, C07531, D00553, EN300-188120, AB00053665-12, AB00053665_13, AB00053665_14, A837435, N-(2-Methylphenyl)-2-(propylamino)propanamide #, Q413598, N-(2-methylphenyl)-2-(propylamino)propanimidic acid, Q-100809, BRD-A53952395-003-05-3, BRD-A53952395-003-15-2, Z44530398, (+/-)-N-(2-PROPYLAMINOPROPIONYL)-2-TOLUIDINE, N-(2,6-DIMETHYLPHENYL)-2-(PROPYLAMINO)PROPANAMIDE
Pubchem:PUBCHEM:4906
Id:3bb78446-891a-5310-a143-8f6ba41ba396
Description:nan
